We are live on
!
Find out more
RG
Redmile Group Portfolio holdings
AUM
$1.51B
1-Year Est. Return
164.17%
This Fund
S&P 500
This Quarter
Est. Return
+9.38%
1 Year Est. Return
+164.17%
3 Year Est. Return
+929.47%
5 Year Est. Return
+823.75%
10 Year Est. Return
+18,826.17%
AUM
$5.45B
AUM Growth
+$30.2M
(+0.56%)
Cap. Flow
+$53.1M
Cap. Flow
% of AUM
0.97%
Top 10 Holdings %
Top 10 Hldgs %
47.61%
Holding
95
New
15
Increased
22
Reduced
33
Closed
14
Top Buys
| 1 |
Gilead Sciences
GILD
|
+$199M |
| 2 |
OSH
Oak Street Health, Inc.
OSH
|
+$119M |
| 3 |
Kymera Therapeutics
KYMR
|
+$83.4M |
| 4 |
Annexon
ANNX
|
+$80.8M |
| 5 |
KLRS
Kalaris Therapeutics
KLRS
|
+$69.3M |
Top Sells
| 1 |
PRNB
Principia Biopharma Inc. Common Stock
PRNB
|
+$162M |
| 2 |
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
|
+$157M |
| 3 |
BioNTech
BNTX
|
+$132M |
| 4 |
HRC
HILL-ROM HOLDINGS, INC.
HRC
|
+$64.2M |
| 5 |
CryoPort
CYRX
|
+$55M |
Sector Composition
| 1 | Healthcare | 92.54% |
| 2 | Financials | 0.5% |
| 3 | Technology | 0% |
| 4 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Fate Therapeutics
FATE
$349M
| $505M | 9.27% |
12,629,737
| – | – |
|
|
FOLD
2
DELISTED
Amicus Therapeutics
FOLD
| $326M | 5.98% |
23,075,807
-1,868,888
| -7% | -$27.2M |
|
|
IMMU
3
DELISTED
Immunomedics Inc
IMMU
| $275M | 5.05% |
3,234,934
-254,966
| -7% | -$12.9M |
|
4
argenx
ARGX
$54B
| $259M | 4.76% |
988,468
-46,400
| -4% | -$11.2M |
|
|
IGMS
5
DELISTED
IGM Biosciences
IGMS
| $253M | 4.64% |
3,425,455
+281,455
| +9% | +$16.7M |
|
|
DCPH
6
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $245M | 4.5% |
4,774,918
-204,023
| -4% | -$9.99M |
|
7
ADC Therapeutics
ADCT
$163M
| $210M | 3.85% |
6,353,094
+827,224
| +15% | +$35.8M |
|
|
ALLK
8
DELISTED
Allakos
ALLK
| $198M | 3.63% |
2,425,560
-193,520
| -7% | -$15.7M |
|
|
9
Gilead Sciences
GILD
$164B
| $181M | 3.33% |
+2,869,962
| New | +$199M |
|
|
OSH
10
DELISTED
Oak Street Health, Inc.
OSH
| $142M | 2.6% |
+2,652,411
| New | +$119M |
|
|
11
Annexon
ANNX
$1.06B
| $104M | 1.91% |
+3,442,122
| New | +$80.8M |
|
|
EPZM
12
DELISTED
Epizyme, Inc
EPZM
| $99.2M | 1.82% |
8,311,633
-173,972
| -2% | -$2.33M |
|
|
ONEM
13
DELISTED
1Life Healthcare
ONEM
| $94.9M | 1.74% |
3,344,694
+334,010
| +11% | +$10.5M |
|
14
Biogen
BIIB
$29.1B
| $92.9M | 1.71% |
327,447
+165,147
| +102% | +$46.1M |
|
15
Nurix Therapeutics
NRIX
$2.48B
| $90.5M | 1.66% |
+2,593,570
| New | +$65.4M |
|
16
Atara Biotherapeutics
ATRA
$77M
| $89.9M | 1.65% |
277,555
+3,820
| +1% | +$1.3M |
|
|
17
Kymera Therapeutics
KYMR
$9.39B
| $88.3M | 1.62% |
+2,732,660
| New | +$83.4M |
|
18
Sanofi
SNY
$105B
| $87.4M | 1.61% |
1,743,048
+517,548
| +42% | +$26.6M |
|
|
19
BioNTech
BNTX
$23.3B
| $85.5M | 1.57% |
1,235,645
-1,833,519
| -60% | -$132M |
|
20
Stoke Therapeutics
STOK
$1.86B
| $85.4M | 1.57% |
2,549,506
+47,200
| +2% | +$1.35M |
|
21
Beam Therapeutics
BEAM
$3.17B
| $81.9M | 1.5% |
3,327,262
-29,696
| -0.9% | -$737K |
|
22
Zentalis Pharmaceuticals
ZNTL
$340M
| $79.5M | 1.46% |
2,432,408
+771,203
| +46% | +$27M |
|
23
Pliant Therapeutics
PLRX
$69.4M
| $76.8M | 1.41% |
3,391,757
-18,900
| -0.6% | -$472K |
|
24
Replimune Group
REPL
$813M
| $76.7M | 1.41% |
3,330,999
+226,806
| +7% | +$5.17M |
|
|
RPTX
25
DELISTED
Repare Therapeutics
RPTX
| $74M | 1.36% |
2,404,974
+18,800
| +0.8% | +$498K |
|
Similar funds
ORI
GAI
HCMG
FMI
FCM
PP
AM
BFO